Filing Details

Accession Number:
0001708138-20-000062
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-05-22 18:21:57
Reporting Period:
2020-05-20
Accepted Time:
2020-05-22 18:21:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc. REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1013064 Roy P Vagelos 777 Old Saw Mill River Road
Tarrytown NY 10591
Chairman Of The Board Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-05-21 683 $577.37 307,849 No 4 S Direct
Common Stock Disposition 2020-05-21 100 $578.34 307,749 No 4 S Direct
Common Stock Disposition 2020-01-03 564 $0.00 144,333 No 5 G Indirect by CLAT
Common Stock Disposition 2020-04-02 433 $0.00 143,900 No 5 G Indirect by CLAT
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 5 G Indirect by CLAT
No 5 G Indirect by CLAT
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2020-05-20 3,264 $0.00 3,264 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-20 77,309 $0.00 77,309 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-20 77,309 $0.00 77,309 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-20 77,309 $0.00 77,309 $30.63
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2020-05-20 77,309 $0.00 77,309 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-12-14 No 4 M Direct
231,927 2020-12-14 No 4 M Direct
154,618 2020-12-14 No 4 M Direct
77,309 2020-12-14 No 4 M Direct
0 2020-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,207 Indirect By 401(k) Plan
Common Stock 83,652 Indirect by Spouse as Trustee
Common Stock 1,203 Indirect by trust for grandch
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 683 shares of Company stock on May 21, 2020 at prices ranging from $577.08 to $577.51. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 21, 2020 at each separate price.
  3. By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
  4. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  5. Form two of two